/ Inolex

Joining David Plimpton, CEO, to champion technology innovation & growth

PHILADELPHIA, PA, September 28, 2022Neil Washburn, Ph.D. has joined the Inolex Executive Team as Interim President. He comes alongside Chief Executive Officer, David Plimpton, to serve on Inolex’s leadership team and further develop the company’s strategic growth.

Inolex is a recognized partner in the industry for its patented technologies that move the beauty and personal care industry forward. Washburn is poised to help the company accelerate its growth in line with the needs of its customers and its current and future innovation platform.

“Innovation is a passion of mine, and I am thrilled to have the opportunity to contribute to the momentum of this company. For me, outcome-oriented innovation means helping strong, talented people thrive, so they can work on solving important challenges. Inolex is already disrupting the ingredient space—my energy will focus on scaling this success by leading near-term initiatives and longer-term strategy as we grow,” said Washburn.

"For me, outcome-oriented innovation means helping strong, talented people thrive, so they can work on solving important challenges." Neil Washburn, Interim President

Washburn joins Inolex after a successful 39-year career at DuPont. He holds a Ph.D. in Analytical Chemistry. Washburn led cross-functional teams across Operations, Research & Development, Marketing, and Business Leadership on a number of transformative projects and high-profile global product initiatives throughout his career. More recently, he has been a strategic advisor to technology and material-oriented start-ups with a focus on sustainability.

“In addition to his technical and business knowledge, Neil exudes our service mindset. His competencies to discern opportunities and make thoughtful decisions is the exact kind of leadership we need as an independent company–complementing our existing Senior Leadership Team as we boldly pursue new customers, new products, and new markets,” said Plimpton.

Related Articles

Inolex Launches AminoSensyl™ Ultra MB

March 2023

The breakthrough amino lipid technology delivers a 100% natural, sustainable replacement for behentrimonium chloride (BTAC).

Read More

Inolex names Michael Dall, CFO and Ron Lopez, VP Operations

February 2023

Indicating a future horizon for the company’s global growth and sustainable operations

Read More

Inolex Welcomes Suzanne S. Mayes to its Board of Directors

February 2023
Mayes, a nationally recognized attorney in municipal and project finance at Cozen O'Connor, joins the Inolex Board.

Read More